Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids

To demonstrate the influence of n-3 PUFA supplementation on cytokine and eicosanoid production in peripheral blood mononuclear cells (PBMCs) of MS patients (MSP), we investigated the impact of a 6-month dietary supplementation with these fatty acids on the levels of interleukin-lbeta (IL-1β), IL-2,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuroimmunology 1995-02, Vol.56 (2), p.143-153
Hauptverfasser: Gallai, Virgilio, Sarchielli, Paola, Trequattrini, Alberto, Franceschini, Maristella, Floridi, Ardesio, Firenze, Caterina, Alberti, Andrea, Benedetto, Daniela Di, Stragliotto, Eduardo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 153
container_issue 2
container_start_page 143
container_title Journal of neuroimmunology
container_volume 56
creator Gallai, Virgilio
Sarchielli, Paola
Trequattrini, Alberto
Franceschini, Maristella
Floridi, Ardesio
Firenze, Caterina
Alberti, Andrea
Benedetto, Daniela Di
Stragliotto, Eduardo
description To demonstrate the influence of n-3 PUFA supplementation on cytokine and eicosanoid production in peripheral blood mononuclear cells (PBMCs) of MS patients (MSP), we investigated the impact of a 6-month dietary supplementation with these fatty acids on the levels of interleukin-lbeta (IL-1β), IL-2, interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) in the supernatants of stimulated PBMCs and serum soluble IL-2 receptors in a group of 20 relapsing-remitting (R-R) MSP and a group of 15 age-matched control individuals (CI). The production of PGE2 and LTB4 in the stimulated PBMCs was also assessed in patient and control groups supplemented with n-3 PUFAs. In both groups, n-3 PUFA supplementation led to a significant decrease in the levels of IL-1β and TNF-α, and this reduction was more pronounced in the 3rd and 6th month of supplementation. An analogous decrease was observed in the levels of IL-2 and IFN-γ produced by stimulated PBMCs, and in the levels of serum soluble IL-2 receptors, n-3 PUFA supplementation also appeared to significantly affect prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) production in PBMCs, both in MSP and the control group. The reduced production of these proinflammatory eicosanoids, and the decrease of some cytokines with an immunohenancing effect as a consequence of n-3 PUFA supplementation, could modulate some immune functions which have been demonstrated to be altered in MSP.
doi_str_mv 10.1016/0165-5728(94)00140-J
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77146597</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>016557289400140J</els_id><sourcerecordid>77146597</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-1afe74029ae3e52e65eaa3091e44a02f9406c1fe4bb93140a87434eca0ffc5b53</originalsourceid><addsrcrecordid>eNp9kc2O1DAQhC0EWmYX3gAknxB7CNiJHScXJDTib7WIA3C2OnZnx5DYwXZA81C8I54f7ZGD1YeqLqv6I-QZZ6844-3r8mQlVd297MU1Y1yw6uYB2fBO1VUnav6QbO4tj8llSj-KSTaivyAXqmuZ4mxD_m73Ofx0HmlCEzG74Cl4S9GZkMAHZ-kSg13NUXGe5h3SBaNbdhhhosMUgqVz8MGvZkKI1OA0JRpG-vkrXSA79DnR1VuMd8H5O2odZoh7mtZlmXAuMhyz_7i8o75q6BKm_eoT5DVCRktHyHlPwTibnpBHI0wJn57nFfn-_t237cfq9suHT9u3t5VppMoVhxGVYHUP2KCssZUI0LCeoxDA6rEXrDV8RDEMfVPuBp0SjUADbByNHGRzRV6cckv3XyumrGeXDsXAY1iTVoqLVvaqGMXJaGJIKeKol-jmUk9zpg-U9AGBPiDQvdBHSvqmrD0_56_DjPZ-6Yyl6G9OOpaSvx1GnUw5pEHrIpqsbXD__-AfnGam2w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77146597</pqid></control><display><type>article</type><title>Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Gallai, Virgilio ; Sarchielli, Paola ; Trequattrini, Alberto ; Franceschini, Maristella ; Floridi, Ardesio ; Firenze, Caterina ; Alberti, Andrea ; Benedetto, Daniela Di ; Stragliotto, Eduardo</creator><creatorcontrib>Gallai, Virgilio ; Sarchielli, Paola ; Trequattrini, Alberto ; Franceschini, Maristella ; Floridi, Ardesio ; Firenze, Caterina ; Alberti, Andrea ; Benedetto, Daniela Di ; Stragliotto, Eduardo</creatorcontrib><description>To demonstrate the influence of n-3 PUFA supplementation on cytokine and eicosanoid production in peripheral blood mononuclear cells (PBMCs) of MS patients (MSP), we investigated the impact of a 6-month dietary supplementation with these fatty acids on the levels of interleukin-lbeta (IL-1β), IL-2, interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) in the supernatants of stimulated PBMCs and serum soluble IL-2 receptors in a group of 20 relapsing-remitting (R-R) MSP and a group of 15 age-matched control individuals (CI). The production of PGE2 and LTB4 in the stimulated PBMCs was also assessed in patient and control groups supplemented with n-3 PUFAs. In both groups, n-3 PUFA supplementation led to a significant decrease in the levels of IL-1β and TNF-α, and this reduction was more pronounced in the 3rd and 6th month of supplementation. An analogous decrease was observed in the levels of IL-2 and IFN-γ produced by stimulated PBMCs, and in the levels of serum soluble IL-2 receptors, n-3 PUFA supplementation also appeared to significantly affect prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) production in PBMCs, both in MSP and the control group. The reduced production of these proinflammatory eicosanoids, and the decrease of some cytokines with an immunohenancing effect as a consequence of n-3 PUFA supplementation, could modulate some immune functions which have been demonstrated to be altered in MSP.</description><identifier>ISSN: 0165-5728</identifier><identifier>EISSN: 1872-8421</identifier><identifier>DOI: 10.1016/0165-5728(94)00140-J</identifier><identifier>PMID: 7860710</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adult ; Cytokines ; Cytokines - biosynthesis ; Dinoprostone - biosynthesis ; Fatty Acids, Omega-3 - administration &amp; dosage ; Humans ; Interferon-gamma - biosynthesis ; Interleukin-1 - biosynthesis ; Interleukin-2 - biosynthesis ; Leukocytes, Mononuclear - metabolism ; Leukotriene B4 ; Leukotriene B4 - biosynthesis ; Lipopolysaccharides - pharmacology ; Middle Aged ; Mononuclear cells ; Multiple sclerosis ; Multiple Sclerosis - metabolism ; n-3 PUFA supplementation ; Prostaglandin E2 ; Receptors, Interleukin-2 - analysis ; Soluble interleukin-2 receptors ; Tumor Necrosis Factor-alpha - biosynthesis</subject><ispartof>Journal of neuroimmunology, 1995-02, Vol.56 (2), p.143-153</ispartof><rights>1995</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-1afe74029ae3e52e65eaa3091e44a02f9406c1fe4bb93140a87434eca0ffc5b53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/016557289400140J$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7860710$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gallai, Virgilio</creatorcontrib><creatorcontrib>Sarchielli, Paola</creatorcontrib><creatorcontrib>Trequattrini, Alberto</creatorcontrib><creatorcontrib>Franceschini, Maristella</creatorcontrib><creatorcontrib>Floridi, Ardesio</creatorcontrib><creatorcontrib>Firenze, Caterina</creatorcontrib><creatorcontrib>Alberti, Andrea</creatorcontrib><creatorcontrib>Benedetto, Daniela Di</creatorcontrib><creatorcontrib>Stragliotto, Eduardo</creatorcontrib><title>Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids</title><title>Journal of neuroimmunology</title><addtitle>J Neuroimmunol</addtitle><description>To demonstrate the influence of n-3 PUFA supplementation on cytokine and eicosanoid production in peripheral blood mononuclear cells (PBMCs) of MS patients (MSP), we investigated the impact of a 6-month dietary supplementation with these fatty acids on the levels of interleukin-lbeta (IL-1β), IL-2, interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) in the supernatants of stimulated PBMCs and serum soluble IL-2 receptors in a group of 20 relapsing-remitting (R-R) MSP and a group of 15 age-matched control individuals (CI). The production of PGE2 and LTB4 in the stimulated PBMCs was also assessed in patient and control groups supplemented with n-3 PUFAs. In both groups, n-3 PUFA supplementation led to a significant decrease in the levels of IL-1β and TNF-α, and this reduction was more pronounced in the 3rd and 6th month of supplementation. An analogous decrease was observed in the levels of IL-2 and IFN-γ produced by stimulated PBMCs, and in the levels of serum soluble IL-2 receptors, n-3 PUFA supplementation also appeared to significantly affect prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) production in PBMCs, both in MSP and the control group. The reduced production of these proinflammatory eicosanoids, and the decrease of some cytokines with an immunohenancing effect as a consequence of n-3 PUFA supplementation, could modulate some immune functions which have been demonstrated to be altered in MSP.</description><subject>Adult</subject><subject>Cytokines</subject><subject>Cytokines - biosynthesis</subject><subject>Dinoprostone - biosynthesis</subject><subject>Fatty Acids, Omega-3 - administration &amp; dosage</subject><subject>Humans</subject><subject>Interferon-gamma - biosynthesis</subject><subject>Interleukin-1 - biosynthesis</subject><subject>Interleukin-2 - biosynthesis</subject><subject>Leukocytes, Mononuclear - metabolism</subject><subject>Leukotriene B4</subject><subject>Leukotriene B4 - biosynthesis</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Middle Aged</subject><subject>Mononuclear cells</subject><subject>Multiple sclerosis</subject><subject>Multiple Sclerosis - metabolism</subject><subject>n-3 PUFA supplementation</subject><subject>Prostaglandin E2</subject><subject>Receptors, Interleukin-2 - analysis</subject><subject>Soluble interleukin-2 receptors</subject><subject>Tumor Necrosis Factor-alpha - biosynthesis</subject><issn>0165-5728</issn><issn>1872-8421</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2O1DAQhC0EWmYX3gAknxB7CNiJHScXJDTib7WIA3C2OnZnx5DYwXZA81C8I54f7ZGD1YeqLqv6I-QZZ6844-3r8mQlVd297MU1Y1yw6uYB2fBO1VUnav6QbO4tj8llSj-KSTaivyAXqmuZ4mxD_m73Ofx0HmlCEzG74Cl4S9GZkMAHZ-kSg13NUXGe5h3SBaNbdhhhosMUgqVz8MGvZkKI1OA0JRpG-vkrXSA79DnR1VuMd8H5O2odZoh7mtZlmXAuMhyz_7i8o75q6BKm_eoT5DVCRktHyHlPwTibnpBHI0wJn57nFfn-_t237cfq9suHT9u3t5VppMoVhxGVYHUP2KCssZUI0LCeoxDA6rEXrDV8RDEMfVPuBp0SjUADbByNHGRzRV6cckv3XyumrGeXDsXAY1iTVoqLVvaqGMXJaGJIKeKol-jmUk9zpg-U9AGBPiDQvdBHSvqmrD0_56_DjPZ-6Yyl6G9OOpaSvx1GnUw5pEHrIpqsbXD__-AfnGam2w</recordid><startdate>19950201</startdate><enddate>19950201</enddate><creator>Gallai, Virgilio</creator><creator>Sarchielli, Paola</creator><creator>Trequattrini, Alberto</creator><creator>Franceschini, Maristella</creator><creator>Floridi, Ardesio</creator><creator>Firenze, Caterina</creator><creator>Alberti, Andrea</creator><creator>Benedetto, Daniela Di</creator><creator>Stragliotto, Eduardo</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19950201</creationdate><title>Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids</title><author>Gallai, Virgilio ; Sarchielli, Paola ; Trequattrini, Alberto ; Franceschini, Maristella ; Floridi, Ardesio ; Firenze, Caterina ; Alberti, Andrea ; Benedetto, Daniela Di ; Stragliotto, Eduardo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-1afe74029ae3e52e65eaa3091e44a02f9406c1fe4bb93140a87434eca0ffc5b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adult</topic><topic>Cytokines</topic><topic>Cytokines - biosynthesis</topic><topic>Dinoprostone - biosynthesis</topic><topic>Fatty Acids, Omega-3 - administration &amp; dosage</topic><topic>Humans</topic><topic>Interferon-gamma - biosynthesis</topic><topic>Interleukin-1 - biosynthesis</topic><topic>Interleukin-2 - biosynthesis</topic><topic>Leukocytes, Mononuclear - metabolism</topic><topic>Leukotriene B4</topic><topic>Leukotriene B4 - biosynthesis</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Middle Aged</topic><topic>Mononuclear cells</topic><topic>Multiple sclerosis</topic><topic>Multiple Sclerosis - metabolism</topic><topic>n-3 PUFA supplementation</topic><topic>Prostaglandin E2</topic><topic>Receptors, Interleukin-2 - analysis</topic><topic>Soluble interleukin-2 receptors</topic><topic>Tumor Necrosis Factor-alpha - biosynthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gallai, Virgilio</creatorcontrib><creatorcontrib>Sarchielli, Paola</creatorcontrib><creatorcontrib>Trequattrini, Alberto</creatorcontrib><creatorcontrib>Franceschini, Maristella</creatorcontrib><creatorcontrib>Floridi, Ardesio</creatorcontrib><creatorcontrib>Firenze, Caterina</creatorcontrib><creatorcontrib>Alberti, Andrea</creatorcontrib><creatorcontrib>Benedetto, Daniela Di</creatorcontrib><creatorcontrib>Stragliotto, Eduardo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neuroimmunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gallai, Virgilio</au><au>Sarchielli, Paola</au><au>Trequattrini, Alberto</au><au>Franceschini, Maristella</au><au>Floridi, Ardesio</au><au>Firenze, Caterina</au><au>Alberti, Andrea</au><au>Benedetto, Daniela Di</au><au>Stragliotto, Eduardo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids</atitle><jtitle>Journal of neuroimmunology</jtitle><addtitle>J Neuroimmunol</addtitle><date>1995-02-01</date><risdate>1995</risdate><volume>56</volume><issue>2</issue><spage>143</spage><epage>153</epage><pages>143-153</pages><issn>0165-5728</issn><eissn>1872-8421</eissn><abstract>To demonstrate the influence of n-3 PUFA supplementation on cytokine and eicosanoid production in peripheral blood mononuclear cells (PBMCs) of MS patients (MSP), we investigated the impact of a 6-month dietary supplementation with these fatty acids on the levels of interleukin-lbeta (IL-1β), IL-2, interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) in the supernatants of stimulated PBMCs and serum soluble IL-2 receptors in a group of 20 relapsing-remitting (R-R) MSP and a group of 15 age-matched control individuals (CI). The production of PGE2 and LTB4 in the stimulated PBMCs was also assessed in patient and control groups supplemented with n-3 PUFAs. In both groups, n-3 PUFA supplementation led to a significant decrease in the levels of IL-1β and TNF-α, and this reduction was more pronounced in the 3rd and 6th month of supplementation. An analogous decrease was observed in the levels of IL-2 and IFN-γ produced by stimulated PBMCs, and in the levels of serum soluble IL-2 receptors, n-3 PUFA supplementation also appeared to significantly affect prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) production in PBMCs, both in MSP and the control group. The reduced production of these proinflammatory eicosanoids, and the decrease of some cytokines with an immunohenancing effect as a consequence of n-3 PUFA supplementation, could modulate some immune functions which have been demonstrated to be altered in MSP.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>7860710</pmid><doi>10.1016/0165-5728(94)00140-J</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0165-5728
ispartof Journal of neuroimmunology, 1995-02, Vol.56 (2), p.143-153
issn 0165-5728
1872-8421
language eng
recordid cdi_proquest_miscellaneous_77146597
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Cytokines
Cytokines - biosynthesis
Dinoprostone - biosynthesis
Fatty Acids, Omega-3 - administration & dosage
Humans
Interferon-gamma - biosynthesis
Interleukin-1 - biosynthesis
Interleukin-2 - biosynthesis
Leukocytes, Mononuclear - metabolism
Leukotriene B4
Leukotriene B4 - biosynthesis
Lipopolysaccharides - pharmacology
Middle Aged
Mononuclear cells
Multiple sclerosis
Multiple Sclerosis - metabolism
n-3 PUFA supplementation
Prostaglandin E2
Receptors, Interleukin-2 - analysis
Soluble interleukin-2 receptors
Tumor Necrosis Factor-alpha - biosynthesis
title Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T13%3A43%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytokine%20secretion%20and%20eicosanoid%20production%20in%20the%20peripheral%20blood%20mononuclear%20cells%20of%20MS%20patients%20undergoing%20dietary%20supplementation%20with%20n-3%20polyunsaturated%20fatty%20acids&rft.jtitle=Journal%20of%20neuroimmunology&rft.au=Gallai,%20Virgilio&rft.date=1995-02-01&rft.volume=56&rft.issue=2&rft.spage=143&rft.epage=153&rft.pages=143-153&rft.issn=0165-5728&rft.eissn=1872-8421&rft_id=info:doi/10.1016/0165-5728(94)00140-J&rft_dat=%3Cproquest_cross%3E77146597%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77146597&rft_id=info:pmid/7860710&rft_els_id=016557289400140J&rfr_iscdi=true